PGNY: Progyny, Inc. - Summary | Jitta

Progyny, Inc.

NASDAQ:PGNY

Price
$18.91
Loss Chance
41.2%
7.22JITTA SCORE
54.74%Under Jitta Line
Jitta Ranking
15 / 717
151 / 4,223
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (76)
Recent Business Performance (83)
Financial Strength (88)
Return to Shareholders (56)
Competitive Advantage (77)
Jitta Signs
Revenue and EarningConsistent High Growth in the past 5 years
Recent Business PerformanceEarning Growth Last Quarter (YoY)
Debt LevelLow Long Term Debt
Share RepurchaseEvery Year
CapExVery Low
SG&A to SalesDecreasing
Cash Conversion CycleLess than 60 days
Operating MarginInconsistent
Key Stats
Jitta Score
Jitta Line
7.22
54.74%
3.07
432.53%
Managed Health Care
4.59
165.13%
2.93
459.74%
4.49
100.00%
COMPANY DESCRIPTION
Progyny, Inc., a benefits management company, provides fertility, family building, and women’s health benefits solutions in the United States. It offers fertility benefits solutions, such as differentiated benefits plan design that includes smart cycle treatment bundle; personalized concierge-style member support services; and a selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides access to the medications needed during their treatment and offers care management services, as well as pregnancy and postpartum, menopause and midlife, benefit and leave navigation, and parent and child wellbeing solutions. In addition, it provides assistance service program where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.